[go: up one dir, main page]

WO2004035819A3 - Oligonucleotides utiles dans la detection d'acides nucleiques d'interet - Google Patents

Oligonucleotides utiles dans la detection d'acides nucleiques d'interet Download PDF

Info

Publication number
WO2004035819A3
WO2004035819A3 PCT/DK2003/000715 DK0300715W WO2004035819A3 WO 2004035819 A3 WO2004035819 A3 WO 2004035819A3 DK 0300715 W DK0300715 W DK 0300715W WO 2004035819 A3 WO2004035819 A3 WO 2004035819A3
Authority
WO
WIPO (PCT)
Prior art keywords
nucleic acids
detecting
oligonucleotide analogues
analyzing nucleic
nucleic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/DK2003/000715
Other languages
English (en)
Other versions
WO2004035819A2 (fr
WO2004035819A8 (fr
Inventor
Sakari Kauppinen
Carsten Alsbo
Peter Stein Nielsen
Daniel Charlton Jeffares
Tobias Mourier
Soeren Moerk
Peter Arctander
Niels Tommerup
Niels Tolstrup
Henrik Vissing
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Exiqon AS
Original Assignee
Exiqon AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Exiqon AS filed Critical Exiqon AS
Priority to EP03757735A priority Critical patent/EP1556510A2/fr
Priority to AU2003273778A priority patent/AU2003273778A1/en
Publication of WO2004035819A2 publication Critical patent/WO2004035819A2/fr
Publication of WO2004035819A3 publication Critical patent/WO2004035819A3/fr
Publication of WO2004035819A8 publication Critical patent/WO2004035819A8/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

L'invention concerne des acides nucléiques améliorés et des procédés destinés au profilage d'expression des ARNm, pour identifier et profiler des variants épissés déterminés d'ARNm et pour détecter les mutations, les délétions ou les duplications d'exons déterminés ou d'autres variants épissés, p.ex., des altérations associées avec des maladies telles que le cancer dans un échantillon d'acide nucléique, p.ex. dans un échantillon biologique ou un échantillons de patient.
PCT/DK2003/000715 2002-10-21 2003-10-21 Oligonucleotides utiles dans la detection d'acides nucleiques d'interet Ceased WO2004035819A2 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
EP03757735A EP1556510A2 (fr) 2002-10-21 2003-10-21 OLIGONUCLEOTIDE ANALOGUE DANS LA DETECTION ET l'ANALYSE D'ACIDES NUCLEIQUES
AU2003273778A AU2003273778A1 (en) 2002-10-21 2003-10-21 Oligonucleotide analogues for detecting and analyzing nucleic acids

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US42027802P 2002-10-21 2002-10-21
US60/420,278 2002-10-21
DKPA200300752 2003-05-19
DKPA200300752 2003-05-19

Publications (3)

Publication Number Publication Date
WO2004035819A2 WO2004035819A2 (fr) 2004-04-29
WO2004035819A3 true WO2004035819A3 (fr) 2004-08-26
WO2004035819A8 WO2004035819A8 (fr) 2004-09-30

Family

ID=32109043

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/DK2003/000715 Ceased WO2004035819A2 (fr) 2002-10-21 2003-10-21 Oligonucleotides utiles dans la detection d'acides nucleiques d'interet

Country Status (3)

Country Link
EP (1) EP1556510A2 (fr)
AU (1) AU2003273778A1 (fr)
WO (1) WO2004035819A2 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106068329A (zh) * 2014-01-08 2016-11-02 基诺泰科有限公司 利用5’‑瓣状内切核酸酶活性被抑制的dna聚合酶并通过实时聚合酶链反应来检测突变基因的方法

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2246748T1 (es) 2002-12-23 2006-03-01 Agilent Technologies, Inc. Ensayos de hibridacion genomica comparativos que utilizan caracteristicas oligonucleotidicas inmovilizadas y composiciones para ponerlos en practica.
US8321138B2 (en) 2005-07-29 2012-11-27 Agilent Technologies, Inc. Method of characterizing quality of hybridized CGH arrays
WO2006076025A2 (fr) * 2004-05-14 2006-07-20 Amaox, Inc. Biocapteurs de cellule immune et procede d'utilisation de ceux-ci
US20080261258A1 (en) * 2004-07-09 2008-10-23 Amaox, Inc. Immune Cell Biosensors and Methods of Using Same
EP2134736A4 (fr) 2007-03-15 2013-05-29 Jyoti Chattopadhyaya Ribothymidines carbocycliques 2', 4' à conformation verrouillée à 5 et 6 éléments destinées à traiter des infections et le cancer
DK2195428T3 (en) 2007-09-19 2014-03-03 Applied Biosystems Llc SIRNA SEQUENCE-INDEPENDENT MODIFICATION FORMS TO REDUCE TARGET-FAILING PHENOTYPIC EFFECTS OF RNAI, AND STABILIZED FORMS THEREOF
WO2012048113A2 (fr) 2010-10-07 2012-04-12 The General Hospital Corporation Biomarqueurs de cancer
US8273235B2 (en) 2010-11-05 2012-09-25 Roshan V Chapaneri Dark colored chromium based electrodeposits
US10301624B2 (en) 2014-06-25 2019-05-28 The General Hospital Corporation Targeting human satellite II (HSATII)
WO2018155451A1 (fr) 2017-02-21 2018-08-30 国立大学法人大阪大学 Composé d'acide nucléique et oligonucléotide
KR20200120675A (ko) 2018-02-14 2020-10-21 딥 지노믹스 인코포레이티드 윌슨병을 위한 올리고뉴클레오티드 요법

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999014226A2 (fr) * 1997-09-12 1999-03-25 Exiqon A/S Analogues d'oligonucleotides
WO2001081632A1 (fr) * 2000-04-25 2001-11-01 Affymetrix, Inc. Technique de surveillance de l'expression de genes alternativement episses
WO2002061387A2 (fr) * 2000-10-25 2002-08-08 Exiqon A/S Plates-formes du type substrat ouvert se pretant a l'analyse de biomolecules

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999014226A2 (fr) * 1997-09-12 1999-03-25 Exiqon A/S Analogues d'oligonucleotides
WO2001081632A1 (fr) * 2000-04-25 2001-11-01 Affymetrix, Inc. Technique de surveillance de l'expression de genes alternativement episses
WO2002061387A2 (fr) * 2000-10-25 2002-08-08 Exiqon A/S Plates-formes du type substrat ouvert se pretant a l'analyse de biomolecules

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
DWAINE A. BRAASCH ET AL: "Locked nucleic acid (LNA): fine-tuning the recognition of DNA and RNA", CHEMISTRY & BIOLOGY, vol. 8, 2001, pages 1 - 7, XP002285000 *
NIELS TOLSTRUP ET AL: "OligoDesign: optimal design of LNA (locked nucleic acid) oligonucleotide capture probes for gene expression profiling", NUCLEIC ACIDS RESEARCH, vol. 31, no. 13, 2003, pages 3758 - 3762, XP002285001 *
See also references of EP1556510A2 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106068329A (zh) * 2014-01-08 2016-11-02 基诺泰科有限公司 利用5’‑瓣状内切核酸酶活性被抑制的dna聚合酶并通过实时聚合酶链反应来检测突变基因的方法
CN106068329B (zh) * 2014-01-08 2020-03-27 基诺泰科有限公司 一种通过实时聚合酶链反应检测突变基因的方法

Also Published As

Publication number Publication date
WO2004035819A2 (fr) 2004-04-29
AU2003273778A1 (en) 2004-05-04
EP1556510A2 (fr) 2005-07-27
WO2004035819A8 (fr) 2004-09-30
AU2003273778A8 (en) 2004-05-04

Similar Documents

Publication Publication Date Title
Claes et al. De novo mutations in the sodium-channel gene SCN1A cause severe myoclonic epilepsy of infancy
WO2004035819A8 (fr) Oligonucleotides utiles dans la detection d'acides nucleiques d'interet
WO2004053079A3 (fr) Compositions, variants d'epissage et methodes concernant des genes et des proteines specifiques des ovaires
WO2003012046A3 (fr) Polymorphisme du gene stk15 (stk6) et methodes de determination du risque de cancer
WO2008107134A3 (fr) Procédé de détection d'un cancer du foie, d'un risque de cancer du foie, d'un risque de récidive de cancer du foie, de la malignité d'un cancer du foie et de la progression d'un cancer du foie dans le temps en utilisant la cytosine méthylée dans le gène basp1a et/ou le gène s
WO2005040396A3 (fr) Systeme d'essai qrt-pcr pour le profilage d'expression genetique
WO2003089897A3 (fr) Diagnostic et traitement de maladie vasculaire
US20110300535A1 (en) Method of identifying individuals at risk of thiopurine drug resistance and intolerance
WO2003020118A3 (fr) Diagnostic et traitement des maladies vasculaires
WO2003054149A3 (fr) Stratification de risque genetique cible au moyen de microreseaux
WO2004050860A3 (fr) Compositions, variants d'epissage et methodes associes aux genes et proteines specifiques du colon
WO2008018789A3 (fr) Procédés et moyens pour diagnostiquer et traiter l'ostéoarthrite
WO2003022875A3 (fr) Polymorphismes de pd-1
WO2005017102A3 (fr) Compositions, variants d'epissage et procedes associes a des acides nucleiques et des proteines specifiques
EP1662006A4 (fr) Molecule d'acide nucleique partiellement double brin
Reiner et al. Restriction enzyme based enriched L1Hs sequencing (REBELseq): a scalable technique for detection of Ta subfamily L1Hs in the human genome
Kalinderi et al. No association of the Val158Met COMT polymorphism with Parkinson's disease in the Greek population
WO2007134718A3 (fr) Utilisation du gène adamts4 et de polymorphismes de protéines
WO2003066877A3 (fr) Compositions et procedes se rapportant a des genes et proteines specifiques hepatiques
WO2004050858A3 (fr) Compositions, variants d'epissage et procedes associe aux genes et proteines specifiques du colon
WO2001020024A3 (fr) Procede pour determiner des sequences d'acides nucleiques et/ou d'acides amines
WO2007131202A3 (fr) Génomique d'une resténose intra-stent
WO2004113568A3 (fr) Méthodes de détection de la maladie d'alzheimer
DE60212930D1 (de) Detektionsmethode für Zielmoleküle, Reagenz sowie Verfahren zur Detektion von SNPs in DNA Nukleotidsequenzen
WO2001032909A3 (fr) Methode permettant de detecter la presence ou l'absence de genes specifiques

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
CFP Corrected version of a pamphlet front page
CR1 Correction of entry in section i

Free format text: IN PCT GAZETTE 18/2004 UNDER (72, 75) ADD "MARK, SÜREN (DK/DK); FENGERSVEJ 3 , DK-2500 VALBY (DK)"

CFP Corrected version of a pamphlet front page

Free format text: UNDER (54) PUBLISHED TITLE REPLACED BY CORRECT TITLE

WWE Wipo information: entry into national phase

Ref document number: 2003757735

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2003757735

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP